Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Neuroblastoma.

H M Meir1, I Balawi, H Nayel

  • 1King Abdul Aziz Hospital, Jeddah, Kingdom of Saudi Arabia.

Saudi Medical Journal
|September 27, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Challenging the arbitrary cutoff score of 60%: Standard setting evidence from preclinical Operative Dentistry course.

Medical teacher·2017
Same author

Neuroblastoma: A clinical review.

Neurosciences (Riyadh, Saudi Arabia)·2013
Same author

Differentiated thyroid carcinoma referred for radioiodine therapy.

Saudi medical journal·2001
Same author

Fever and granulocytopenia in children with acute lymphoblastic leukemia under induction therapy.

Saudi medical journal·2001
Same author

Gigantic jejunal leiomyosarcoma.

Saudi medical journal·2001
Same author

Hepatic dysfunction in children with acute lymphoblastic leukemia in remission: relation to hepatitis infection.

Medical and pediatric oncology·2001
Same journal

Molecular Mechanisms of Diffuse Large B-Cell Lymphoma and the Complexities of Tumor Development.

Saudi medical journal·2026
Same journal

Polysomnographic and Clinical Characteristics of Narcolepsy in Saudi Arabia: <i>A 12-Year Retrospective Study</i>.

Saudi medical journal·2026
Same journal

Etiology, Management, and Outcomes of Hospitalized Heart Failure Patients: <i>A Single-Center Study</i>.

Saudi medical journal·2026
Same journal

Effect of Anesthetic Agents on Middle Ear Pressure: Systematic Review and Meta-Analysis.

Saudi medical journal·2026
Same journal

Evaluation of Raqeem Health Information System in Primary Healthcare Centers in Makkah, Saudi Arabia, Using the DeLone and McLean Information System Success Model.

Saudi medical journal·2026
Same journal

Integrating Traditional and Complementary Medicine into Saudi Primary Care: <i>A Literature Review in Light of the WHO 2025-2034 Strategy</i>.

Saudi medical journal·2026
See all related articles

Intensive multimodal therapy offers neuroblastoma patients, even with advanced stages, a chance for symptom-free and sometimes disease-free survival. Partial response to initial therapy still warrants continued treatment for improved outcomes in these children.

Area of Science:

  • Pediatric Oncology
  • Medical Oncology

Background:

  • Neuroblastoma is a common childhood cancer, with advanced stages presenting significant treatment challenges.
  • The efficacy and cost-effectiveness of aggressive treatments like myeloablative therapy for stage IV neuroblastoma remain debated.
  • Retrospective analysis is crucial for evaluating treatment outcomes in rare pediatric cancers.

Purpose of the Study:

  • To retrospectively analyze treatment outcomes in 43 children diagnosed with neuroblastoma.
  • To specifically evaluate the rate and duration of remission in patients with disseminated (stage IV) neuroblastoma.
  • To inform treatment decisions regarding aggressive therapy for advanced-stage neuroblastoma.

Main Methods:

  • Surgical tumor removal followed by combination chemotherapy for unresectable or metastatic disease.

Related Experiment Videos

  • Alternating chemotherapy regimens included Cyclophosphamide, Vincristine, Doxorubicin, Cis-platinum, and Etoposide.
  • Second-look surgery was employed to resect residual tumor masses after chemotherapy.

    • Main Results:

    • The majority of patients (70%) presented with disseminated disease; 14% had localized tumors (stages I/II), and 5% had stage IV.
    • Among evaluable stage IV patients, significant response rates were observed: 4 complete remissions, 7 very good partial remissions, and 8 partial remissions.
    • Despite advanced disease, 78% of patients were symptom-free, and some achieved long-term remission (up to 42 months).

    Conclusions:

    • Multiagent chemotherapy regimens demonstrate effectiveness in treating children with advanced-stage neuroblastoma.
    • Intensive multimodal therapy should be considered for all neuroblastoma patients, including those with a partial response to initial treatment.
    • These treatment strategies can lead to reasonable symptom-free and potentially disease-free survival.